Adaptimmune Therapeutics (ADAP) null Earnings

5NovConfirmed
Feb 20
May 20
Aug 20
Nov 20
-0.34
-0.3
-0.27
-0.23

Details

Expected EPS
-0.25
Actual EPS
-0.24
Surprise EPS
0.01
Surprise Percent
+4%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.24 per share for .

0 Comments

Share your thoughts